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Abstract
Background: There is a scarcity of epidemiological researches examining the relationship between blood pressure
(BP) and glucose level among older adults. The objective of the current study was to investigate the association of
high BP and glucose level in elderly Chinese.
Methods: A cross-sectional study of a population of 2092 Chinese individuals aged over 65 years was conducted.
Multiple logistic analysis was used to explore the association between hypertension and hyperglycemia.
Independent risk factors for systolic and diastolic BP were analyzed using stepwise linear regression.
Results: Subjects in impaired fasting glucose group (IFG) (n = 144) and diabetes (n = 346), as compared with normal
fasting glucose (NFG) (n = 1277), had a significant higher risk for hypertension, with odds ratios (ORs) of 1.81 (95 % CI,
1.39–2.35) (P = 0.000) and 1.40 (95 % CI, 1.09–1.80) (P = 0.009), respectively. Higher fasting plasma glucose (FPG) levels in
the normal range were still significantly associated with a higher prevalence of hypertension in both genders, with ORs
of 1.24 (95 % CI, 0.85–1.80), R2 = 0.114, P = 0.023 in men and 1.61 (95 % CI, 1.12–2.30), R2 = 0.082, P = 0.010 in women,
respectively, when compared with lower FPG. Linear regression analysis revealed FPG was an independent factor of
systolic and diastolic BP.
Conclusions: Our findings suggest that hyperglycemia as well as higher FPG within the normal range is associated
with a higher prevalence of hypertension independent of other cardiovascular risk factors in elderly Chinese. Further
studies are needed to explore the relationship between hyperglycemia and hypertension in a longitudinal setting.
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Background
Metabolic syndrome is defined as the occurrence of 3 of
any of the 5 following factors: abdominal obesity, ele-
vated triglyceride (TG), low high-density lipoprotein
cholesterol (HDL-c), elevated blood pressure (BP) and
elevated fasting glucose level [1]. It is well known that
metabolic syndrome increases the risk for morbidity and
mortality from cardiovascular diseases [2, 3]. Actually,
the coexistence of hypertension and diabetes alone con-
fers 2–3 times the risk for cardiovascular morbidity and
mortality as for people without diabetes [4, 5]. Epi-
demiological research established that hypertension is
more common in subjects with diabetes mellitus (DM)
than in the general population [6, 7]. On the other hand,
higher BP is associated with increased risk of diabetes
[8–12], even in individuals with normotension [7]. How-
ever, current studies evaluating the relationship of BP
with blood glucose level were limited to age of younger
[8–10], or from across the age spectrum [6, 7, 13], did
not separate out the data of elderly subjects. Further-
more, referral-based samples in most were mainly with
hyperglycemia and hypertension [6, 7, 11, 12]. Some
studies relied on self-reported DM or BP [8–10].
Considering the influence of hypertension or hypergly-
cemia on vascular disease and mortality are age-specific
[13], we therefore conducted a cross-sectional survey
study in a well-characterized community-based sample
of individuals in East China aged over 65 to assess
* Correspondence: fengbo@medmail.com.cn
†Equal contributors
1Department of Endocrinology, Shanghai East Hospital, Tongji University
School of Medicine, 150 Jimo Road, Shanghai 200120, China
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yan et al. BMC Endocrine Disorders  (2016) 16:40 
DOI 10.1186/s12902-016-0119-5
whether higher fasting plasma glucose (FPG) is inde-
pendently associated with a higher prevalence of hyper-
tension, and conversely, whether higher BP is associated




A cross-sectional study was conducted in Shanghai
Pudong New Area between January 2012 and March
2012. Residents who had lived here over 5 years were re-
cruited. Among the 2777 individuals who were aged over
65 year, 2250 subjects participated in the current study.
Inclusion criteria were: (i) men or women aged over
65 year; (ii) with no severe chronic disease or systemic dis-
ease; (iii) willing and able to give informed consent; and
(iv) with complete data on key research variables. Subjects
with medical diseases such as cardiac disease (heart fail-
ure), chronic liver and kidney dysfunction (including
serum alanine aminotransferase > 120 IU/l, and aspartate
aminotransaminase >80 IU/l, and serum creatinine >
2.0 mg/dl), acute infection, severe systemic diseases (e.g.,
cancer) or Acquired Immune Deficiency Syndrome
(AIDS) as well as patients who had secondary hyperten-
sion were excluded (n = 89). Those with incomplete data
on key research variables were also excluded (n = 69). Sub-
sequently, 2092 individuals (971 men and 1121 women)
were included in the current analysis (Fig. 1).
All participants were screened with regard to medical
history (i.e., smoking, alcohol consumption, and medical
treatments). Current smokers were defined as those who
currently smoke every day or some days and who
reported having smoked over 100 cigarettes during their
lifetimes. Alcohol consumption was defined as having up
to 20–30 g of ethanol per day for men and up to 10–20
g of ethanol per day for women. Details of this survey
have been reported previously [14]. Written informed
consent was obtained from all participants.
BP Measurements
BP was measured using a mercury sphygmomanometer
by an experienced physician. Subjects were in a seated
position with an arm flexed at the level of the heart.
After the cuff was wrapped around the upper arm with
the cuff ’s lower edge one inch above the antecubital
fossa, the cuff was rapidly inflated to 180 mmHg. Then
air was released from the cuff at a rate of 3 mm/s. Dur-
ing this period, the physician listened carefully with a
stethoscope while simultaneously observing the sphyg-
momanometer. The first knocking sound (Korotkoff )
was the subject’s systolic pressure. When the knocking
sound disappeared, that was the diastolic pressure. BP
was measured in either the right upper or left upper arm
after each subject had been seated for at least 10 min.
The arm with the higher blood pressure would be mea-
sured twice. The average was used for analysis. If the dif-
ference of SBP or DBP between the twice was over
5 mmHg, it would be measured for the third time, and
then the average of three times was used for analysis.
Hypertension was defined as systolic blood pressure
(SBP) ≥140 mmHg and/or diastolic blood pressure (DBP)
≥90 mmHg or reported receiving antihypertensive medi-
cation. Participants who were diagnosed hypertensive for
the first time during this survey were called new-onset
2777 residents who were 
over 65 years in 11 urban of 
Pudong Area
2250 individuals agreed to 
participate in the study
2161 individuals were 
eligible
2092 individuals (971 men and 
1121 women) were enrolled at 
last
527 subjects did not agree to 
participate in the study 
89 subjects with medical illnesses such as cardiac, 
renal, liver, or endocrine disease, severe systemic 
diseases, AIDS or secondary hypertension were 
excluded
69 subjects with incomplete data on 
key research variables were excluded
Fig. 1 Study design and participant flow diagram for the present study
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hypertension; participants who had a history of hyperten-
sion were called previously-diagnosed hypertension. High-
normal BP was defined as not having hypertension, and
with SBP 120–139 mmHg or DBP 80–90 mmHg; normal
BP included SBP < 120 mmHg and DBP < 80 mmHg and
with no antihypertensive treatment [15].
DM Ascertainment
Participants were considered to have DM if fasting blood
glucose ≥ 7.0 mmol/L or reported using insulin or oral
hypoglycemic medication. Participants who were diag-
nosed DM for the first time during this survey were
called new-onset DM, participants who had a history of
DM were called previously-diagnosed DM. Normal fast-
ing glucose (NFG) was defined as FPG < 6.1 mmol/L.
Impaired fasting glucose (IFG) was defined as FPG ≥
6.1 mmol/L but <7.0 mmol/L according to WHO cri-
teria, 1999 [16].
Covariates
Height and weight of all subjects were measured in light
clothes with no shoes. Waist circumference was mea-
sured at the level midway between the lower rib margin
and the iliac crest. Body mass index (BMI) was calcu-
lated as weight (kg) divided by the square of height (m).
Blood samples were collected from venous blood after
overnight fasting, and FPG, total cholesterol and trigly-
ceride were measured. Glucose measurement was done
in a central lab in Shanghai East Hospital. Plasma fasting
glucose level was determined in NaF preserved plasma
using the glucose oxidase method by automatic analyzer,
Accurizer Autochem 400 (Affinitech, China).
Statistical analysis
Continuous data were summarized by the mean ± SD or
median, and categorical data by number (percentages).
All of the continuous data had skewed distribution even
after logarithmically transformed. Mann–Whitney test
(for data that was not normally distributed) and Chi-
square test (for data that were categorical variables) were
used to compare the differences between the Men and
Women groups.
The participants were divided into 4 groups according
to FPG levels: NFG (n = 1277), IFG (n = 144), New-onset
DM (n = 325), and previously-diagnosed DM (n = 346).
Binary logistic analysis was used to examine the associ-
ation of hyperglycemia status with hypertension. Then
NFG group was further divided into two subgroups ac-
cording to the median FPG level by sex. Multiple logistic
analyses were used to explore the associations between
hypertension and hyperglycemia. Independent risk fac-
tors for systolic and diastolic pressure were analyzed
using stepwise linear regression.
Results
Clinical characteristics
The baseline characteristics of the study population by
sex were shown in Table 1. The study population con-
sisted of 2092 (971 men and 1121 women, mean age
72.8 and 73.6 years, respectively). The prevalence of total
DM in men and women were 23.1 % and 23.7 %, re-
spectively (P = 0.381). The prevalence of hypertension in
men and women were 45.3 % and 48.5 %, respectively
(P = 0.077). There were no significant differences in the
prevalence of IFG and high-normal BP between the
sexes. Other metabolic and anthropometric variables,
except for BMI and FPG, were significantly different be-
tween the sexes (all P < 0.05).
Association of FPG and risk of hypertension
After adjusting for sex, age, smoking, alcohol using,
BMI, TG and TC levels, subjects in IFG and previously-
diagnosed DM, as compared with NFG (<6.1 mmol/L),
had a significant higher risk for hypertension in whole
sample, with odds ratios (OR) of 1.81 (95 % CI, 1.39–
2.35) (P = 0.000) and 1.40 (95 % CI, 1.09–1.80) (P =
0.009), respectively. Subjects in the IFG group were also
associated with an increased OR of new-onset hyperten-
sion (OR 1.68 [95 % CI, 1.18–2.41], P = 0.004) when
comparing with NFG. Of note, there were strong
Table 1 Baseline characteristics by sex
Parameters Men Women P value
Number 971 1121
Age(y) 72.8 ± 6.4 73.6 ± 7.0 0.027
Current smoker n (%) 215(22.1 %) 27(2.4 %) 0.000
Alcohol consumption n (%) 143(14.7 %) 17(1.5 %) 0.000
T2DM n (%) 224(23.1 %) 266(23.7) 0.381
IFG n (%) 142(14.6 %) 167(14.9 %) 0.455
Hypertension n (%) 440(45.3 %) 544(48.5 %) 0.077
High-normal BP n (%) 427(44.0 %) 489(43.6 %) 0.453
BMI(kg/m2) 23.7 ± 3.3 23.9 ± 3.8 0.316
WC(cm) 87.9 ± 9.1 85.4 ± 10.3 0.000
SBP (mmHg) 133.7 ± 16.1 135.4 ± 15.8 0.013
DBP (mmHg) 78.6 ± 8.9 77.4 ± 8.6 0.002
FPG (mmol/L, Mean) 6.2 ± 1.6 6.3 ± 1.8 0.268
FPG (mmol/L, Median) a 5.45 5.51 0.268
TG (mmol/L) 1.5 ± 0.9 1.6 ± 0.9 0.000
TC (mmol/L) 5.2 ± 1.0 5.8 ± 1.0 0.000
Categorical data were described as n (%) and continuous data were described
as means ± SD
BMI body mass index, WC waist circumference, SBP systolic blood pressure,
DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglyceride, TC
total cholesterol
aThe median of FPG in subjects with normal fasting glucose
level (<6.1 mmol/L)
P values < 0.05 were considered significant
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associations of hyperglycemic status with SBP and but
not DBP (Table 2).
The median of FPG was 5.45 mmol/L in men, and
5.51 mmol/L in women respectively in NFG group
(Table 3). NFG group was further divided into two sub-
groups according to the median FPG level by sex. Even
in the normal range of FPG, using below the median
level of FPG as the reference, when adjusting for age,
smoking and alcohol consumption (Model 1), higher
FPG above the median was still significantly associated
with a higher prevalence of hypertension in both gender,
with OR of 1.93 (95 % CI, 1.60–2.34) (R2 = 0.028, P =
0.000) in men and 1.96 (95 % CI, 1.51–2.54) (R2 = 0.033,
P = 0.000) in women respectively. After further adjusting
for BMI, WC, TG and TC (Model 2), the association be-
tween higher FPG and the prevalence of hypertension
was attenuated but remained statistically significant (OR
1.24 [95 % CI, 0.85–1.80], R2 = 0.114, P = 0.023 in men
and 1.61 [95 % CI, 1.12–2.30], R2 = 0.082, P = 0.010 in
women respectively). Similar associations were found be-
tween higher FPG levels and higher SBP in both genders.
However, we did not find any association between higher
FPG and higher DBP in both genders in Model 2.
Table 4 showed the independent risk factors for SBP
and DBP in whole sample and in individuals without
hypoglycemic nor antihypertensive drugs (n = 924) by
stepwise linear regression analysis. After adjusting for
sex, age, smoking, alcohol consumption, BMI, WC, TC,
and TG, FPG levels were significantly associated with
SBP in both samples (β = 0.10, R2 = 0.013, P < 0.01 in
whole sample and β = 0.12, R2 = 0.013, P < 0.01 in indi-
viduals without hypoglycemic or antihypertensive drugs
respectively). As for DBP, FPG levels were also associ-
ated with DBP in individuals without hypoglycemic or
antihypertensive drugs (β = 0.08, R2 = 0.006, P < 0.05).
Association of BP and risk of hyperglycemia
We explored the possible effect of high-normal BP and
hypertension on the risk of IFG and DM by using multiple
logistic regression analysis (Table 5). After adjusting for
age, sex, smoking and alcohol consumption, when com-
pared with the normal BP group, hypertensives had a
significantly higher prevalence of IFG (OR 3.92 [95 % CI,
2.17–7.10], P < 0.01), and DM (2.83 [95 % CI, 1.83–4.38],
P < 0.01) respectively, and subjects with high-normal BP
had a similarly increased prevelance in IFG and DM (OR
2.07 [95 % CI, 1.13–3.78], P < 0.05, and OR 1.78 [95 % CI,
1.14–2.76], P < 0.05, respectively) (Table 5, Model 1).
When further adjusting for BMI, WC, TG, and TC, the as-
sociations between hypertension and IFG and DM
remained statistically significant, though attenuated (OR
3.17 [95 % CI, 1.70–5.68], P < 0.01, and 1.93 [95 % CI,
1.22–3.04], P < 0.01, respectively). Similar associations
were also seen between high-normal BP and IFG, but not
DM (Table 5, Model 2).
Discussion
The close relationship between diabetes and hyperten-
sion has been recognized since the 1980s [6, 10], but
how much this effect varies by race-ethnicity, age or
levels of traditional risk factors is uncertain. The extent
to which glucose concentration is associated with ele-
vated blood pressure is also uncertain. The data for pure
elders in China is more limited. In our present study, we
aimed to explore the association of diabetes and FPG
concentration with hypertension or high-normal BP in a
select groups of elderly subjects in China. We found
that, compared with subjects with NFG, subjects with
IFG and previously-diagnosed DM had a higher preva-
lence of hypertension. Even among the subjects with
NFG, higher FPG was still associated with a higher
prevalence of hypertension after adjusting for covariates
such as age, smoking, alcohol consumption, BMI, WC,
TG, and TC level. FPG was an independent factor of
systolic and diastolic BP. Conversely, multiple analyses
revealed that subjects with hypertension also had a
higher prevalence of IFG and DM.
Our study is comply with other studies that have indi-
cated an increased risk for hypertension and other
cardiovascular risk factors in diabetic individuals as well
as in impaired glucose regulation than those with NFG
[6, 7, 17, 18]. Our study extends this observation by il-
lustrating that a high but normal FPG level was also a
risk factor for hypertension in elderly Chinese subjects,
Table 2 Logistic regression analysis of association of hyperglycemia status with risk of hypertensiona
SBP≥ 140 mmHg DBP ≥ 90 mmHg Total Hypertension New-onset Hypertension
OR (95 % CI) P value OR (95 % CI) P value OR (95 % CI) P value OR (95 % CI) P value
NFG 1 - 1 - 1 - 1 -
IFG 1.89(1.46–2.45) 0.000 1.31(0.94–1.84) 0.111 1.81(1.39–2.35) 0.000 1.68(1.18–2.41) 0.004
New-onset DM 1.44(0.99–1.65) 0.053 1.23(0.78–1.95) 0.375 1.35(0.93–1.94) 0.115 1.49(0.91–2.42) 0.113
Previously-diagnosed DM 1.46(1.13–1.87) 0.003 1.02(0.72–1.44) 0.913 1.40(1.09–1.80) 0.009 0.90(0.61–1.33) 0.592
NFG normal fasting glucose, IFG impaired fasting glucose, New-onset DM, newly diagnosed diabetes mellitus; Previously-Diagnosed DM, previously diagnosed
diabetes mellitus; New-onset hypertension, newly diagnosed hypertension; OR (95 % CI), odds ratio (95 % confidence index); other abbreviations see Table 1
aAdjusted for sex, age, smoking, alcohol consumption, BMI, TG and TC level
P values < 0.05 were considered significant
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and this relation was independent of other traditional
cardiovascular risk factors. What’s more, we found that
elevated FPG was independently associated with an in-
creased risk of SBP and DBP. This is also in line with
two recent studies [19, 20]. In Di Bonito P’s study among
Southern European Caucasian children and adolescents
(age 6–16 years), they found that subjects with high-
normal FPG (83–99 mg/dL) had 1.57–2.23 times the risk
for hypertension when compared with subjects with
low-normal FPG (≤82 mg/dL) independent of BMI [19].
In a cohort study of a Japanese population (age 20–80
years), Y Heianza found that elevated concentration of
FPG in normal range (<4.9 mmol/L vs. 4.9–5.6 mmol/L)
was associated with higher risk of developing
hypertension (OR 1.35–1.39) during a 5-year follow-up
after adjusting for age and gender [20].
Our data also matches with other epidemiological data
demonstrating that basal BP and BP progression are
strong and independent predictors of incident hypergly-
cemia [7, 10–12, 18], and is also consistent with clinical
trial data demonstrating that lower BP are associated
with lower risk of cardiovascular diseases [13]. In the
Women’s Health Study in the USA by David Conen et
al, a baseline BP of 130-139/85-89 mmHg and hyperten-
sion will increase risk of incident Type 2 diabetes in the
following 10 years by 1.45–2.03 times [7]. In a recent
study of Chinese subjects in Hong Kong aged over
18 years, Sau NF found that subjects with IFG were
Table 3 Logistic regression analysis of risk of hypertension in subjects with NFG (above vs. below the median fasting glucose
level a)
Men Women
OR (95 % CI, below vs above
the median $)
P value# Adjusted R2 OR (95 % CI, below vs above
the median $)
P value# Adjusted R2
Total Hypertension
Model 1 1.93(1.60–2.34) 0.000 0.028 1.96(1.51–2.54) 0.000 0.033
Model 2 1.24(0.85–1.80) 0.023 0.114 1.61(1.12–2.30) 0.010 0.082
SBP≥ 140 mmHg
Model 1 2.04(1.54–2.70) 0.000 0.022 2.03(1.56–2.65) 0.000 0.026
Model 2 1.50(1.07–2.10) 0.019 0.058 1.27(0.93–1.74) 0.013 0.071
DBP≥ 90 mmHg
Model 1 1.21(0.84–1.75) 0.301 0.022 1.67(1.12–2.67) 0.011 0.063
Model 2 0.72(0.46–1.15) 0.167 0.048 1.35(0.85–2.12) 0.201 0.015
Abbreviations see Tables 1 and 2
Model 1, adjusted for age, smoking and alcohol using
Model 2, adjusted for age, smoking, alchol using, BMI, WC, TG and TC level
aThe median fasting glucose level was 5.45 mmol/L in men and 5.51 mmol/L in women respectively
P values < 0.05 were considered significant
Table 4 Stepwise linear regression analysis of risk factors for SBP and DBP
All subjects (n = 2092) Subjects without hypoglycemic or antihypertensive drugs (n = 924)
SBP DBP SBP DBP
β R2 β R2 β R2 β R2
BMI (kg/m2) 0.15** 0.034 0.13** 0.032 0.15** 0.028 0.42 -
FPG (mmol/L) 0.10** 0.013 0.022 - 0.12** 0.013 0.08* 0.006
Age (years) 0.09** 0.008 -0.16** 0.019 0.07* 0.004 -0.17** 0.026
Smoking −0.07 - −0.03 - −0.13* 0.012 −0.23 -
(yes/no)
Alcohol consumption 0.06** 0.003 0.021 - 0.07* 0.004 0.026 -
(yes/no)
TC (mmol/L) 0.05* 0.003 0.09** 0.005 0.04 - 0.061 -
TG (mmol/L) 0.07** 0.002 0.05* 0.007 0.01 - -0.34 -
Male (vs.Female) 0.02 - −0.09 - 0.03 - 0.109 -
WC(mmol/L) 0.57 - 0.61 - 0.09 - 0.14** 0.021
Abbreviations see Table 1
* P value < 0.05; **P value < 0.01
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more likely to develop diabetes within 5 years if they
were hypertensive (aHR = 1.44) [11]. A large Japanese
cohort study also showed that having both high-normal
BP and hypertension in middle age was associated with
increased risk of developing diabetes [9]. In our present
study, we also found high-normal BP associated with
risk of IFG after adjusting for conventional risk factors.
Although the association between hypertension and
hyperglycemia has long been discussed, the underlying
biological basis mediating this clinical association re-
mains unclear. Hyperinsulinemia, an important compo-
nent of the metabolic syndrome, may be one of the main
factors [21]. Insulin resistance, which further contributes
to hyperinsulinemia, often progresses to Type 2 diabetes
[22]. In addition, the resistance in the hemodynamic
properties of insulin may impair the blood flow in per-
ipheral tissues, which indirectly contributes to the devel-
opment of the atherogenic dysglycemia and dyslipidemia
[23]. Hyperinsulinemia may directly contribute to
elevation of blood pressure by increasing renal sodium
retention [24] and enhancing sympathetic nervous sys-
tem activity [25], whereas chronic sympathetic nervous
system overactivity may contribute to a further increase
of insulin resistance creating a vicious circle that may
lead to the development of hypertension and diabetes.
In addition, insulin resistance is also associated with a
decreased vasodilatory response to insulin in peripheral
tissue [26, 27] and an increased vasoconstrictor response
to various vasopressors [28, 29], which mainly results
the increase of systolic blood pressure. The pathophysio-
logical mechanism linking insulin and hypertension is
complex and still needs to be fully elucidated.
Our present study adds to the literature by demon-
strating that hyperglycemia is closely correlated with
hypertension in a population of the elderly. We were
able to explore the associations between blood glucose
levels and BP in a relative large, well-defined cohort.
However, several potential limitations of the study merit
Table 5 Multiple logistic regression analysis of risk of IFG and DM
IFG DM
OR (95 % CI) Adjusted R2 OR (95 % CI) Adjusted R2
Model 1 a 0.045 0.028
Age (years) 1.01(0.99–1.03) 1.00(0.99–1.02)
Male (vs. female) 0.95(0.73–1.25) 0.99(0.78–1.24)
Smoking(yes/no) 0.92(0.68–1.08) 1.01(0.85–1.21)
Alcohol consumption (yes/no) 1.06(0.84–1.43) 0.93(0.76–1.41)




Model 2 b 0.095 0.140
Age (years) 1.01(0.99–1.03) 1.01(0.99–1.03)
Male (vs. female) 0.96(0.71–1.30) 0.97(0.81–1.18)
Smoking(yes/no) 0.83(0.65–1.05) 0.92(0.74–1.14)
Alcohol consumption (yes/no) 1.09(0.86–1.39) 0.99(0.77–1.28)
BMI (kg/m2) 1.02(0.95–1.09) 1.04(0.99–1.10)**
WC(mmol/L) 1.03(1.00–1.06)* 1.04(1.02–1.06)**
TG (mmol/L) 1.42(1.22–1.66)** 1.55(1.36–1.77)**
TC (mmol/L) 0.96(0.84–1.10) 0.95(0.85–1.06)




Abbreviations see Tables 1 and 2
Normal BP, SBP < 120 mmHg and DBP < 80 mmHg and not using antihypertensive medication; high-normal BP, SBP 120–139 mmHg or DBP 80–90 mmHg;
hypertension, SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or using antihypertensive medication
aModel 1: Logistic regression analysis with IFG and DM as dependent variable respectively, and age, male (vs. female), smoking, alcohol consumption, and
high-normal BP (vs. normal BP) and hypertension (vs. normal BP) as independent variables
bModel 2: Model 1 + BMI, WC, TG and TC
* P value < 0.05; **P value < 0.01
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discussion. First, because of the observational nature of
the study, we cannot infer causality from our present
data. Second, lack of evaluation of postprandial blood
glucose level and repeated FPG measurement should
underestimate the prevalence of diabetes in this popula-
tion. As this was a survey based on the elderly popula-
tion, postprandial blood glucose measurement may pose
certain problems for the elderly, as they would need to
wait 2 h for venous draw blood after a meal. Third, al-
though multiple potential confounders have been ad-
justed for, we cannot completely rule out the residual
confounders attributed to the inaccurate measurement
of confounders, or some unmeasured confounders.
Conclusions
Our study suggests that hyperglycemia as well as a high
but normal FPG level was associated with a higher
prevalence of hypertension independent of other cardio-
vascular risk factors among elderly Chinese. On the
other hand, hypertension, even high-normal BP, was also
associated with a higher prevalence of hyperglycemia.
Further studies are needed to explore the relationship
between hyperglycemia and hypertension in a longitu-
dinal setting.
Abbreviations
BP, blood pressure; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol;
DM, diabetes mellitus; FPG, fasting plasma glucose; AIDS, acquired immune
deficiency syndrome; SBP, systolic blood pressure; DBP, diastolic blood pressure;
NFG, normal fasting glucose; IFG, impaired fasting glucose; BMI, body mass
index; TC, total cholesterol
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